Center for Global Health, National Cancer Institute (NCI), NIH
Julia Gage, PhD, MPH leads the development of embedded implementation research approaches to bridge implementation science and practice in limited-resource health care settings, accelerating bidirectional learning across diverse global contexts. Currently she is focused on facilitating the introduction of HPV-based cervical cancer screening programs while rapidly disseminating best practices to widespread adoption.
Dr. Gage joined the NCI in 2005 while obtaining her PhD in epidemiology from Johns Hopkins University. As a fellow and later Staff Scientist in the Division of Cancer Epidemiology and Genetics, her research focused on translating novel HPV natural history discoveries into improved screening and diagnosis for cervical precancer, with particular focus on identifying and bringing forth new technologies for cervical cancer prevention to low-resource settings.
Dr. Gage has served as NCI-lead for multiple NCI studies including: the NCI/Brazilian Management of Risk of Cervical Cancer (MARCO) study to evaluate the effectiveness and cost-effectiveness of novel cervical screening and triage strategies, a Rwandan study of the impact of prophylactic HPV vaccination on HPV immunity and HPV infection in women living with HIV, and Project Itoju (Care) – Epidemiologic and molecular features of cervical cancer in Nigeria. She has worked with governmental partners on national screening programs in El Salvador and Peru and served on several WHO Screening and Management Guidelines committees.